Drug interactions
Brexucabtagene autoleucel + Cladribine
Severity: Major
Brexucabtagene autoleucel and Cladribine: major interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Cladribine depletes lymphocytes and may compromise collection, expansion, and activity of CAR-T cells. It also adds to the infection risk from immunosuppression.
What this interaction means in plain words
Brexucabtagene autoleucel and Cladribine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Brexucabtagene autoleucel belongs to Oncology; Cladribine belongs to Oncology.
Why it happens
Lymphotoxic effect of cladribine reduces T-cell numbers and function, affecting CAR-T manufacturing and expansion, and adds to immunosuppression.
What to do
Avoid cladribine before leukapheresis and CAR-T infusion, observing the washout interval in the product labeling. Monitor for infections if exposure has occurred.
What to ask your pharmacist
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Brexucabtagene autoleucel and Cladribine, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Cladribine
- Adenovirus types 4 and 7 live + Cladribine Contraindicated
- Cladribine + Siponimod Contraindicated
- Cladribine + Tofacitinib Contraindicated
- Axicabtagene ciloleucel + Cladribine Major
- Belatacept + Cladribine Major
- Cholera vaccine + Cladribine Major
Other interactions of Brexucabtagene autoleucel
Frequently asked questions
Can I take Brexucabtagene autoleucel with Cladribine?
MediHelp rates the interaction as major. Brexucabtagene autoleucel and Cladribine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Cladribine depletes lymphocytes and may compromise collection, expansion, and activity of CAR-T cells. It also adds to the infection risk from immunosuppression.
How serious is the interaction between Brexucabtagene autoleucel and Cladribine?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid cladribine before leukapheresis and CAR-T infusion, observing the washout interval in the product labeling. Monitor for infections if exposure has occurred.
What other medicines interact with Cladribine?
MediHelp also lists interactions of Cladribine with, for example, Adenovirus types 4 and 7 live, Siponimod, Tofacitinib. The full list is on the Cladribine page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
